GlaxoSmithKline, Johnson & Johnson and DaVita HealthCare Partners had invested in the medical device provider before it floated above its range.
CVRx, a US-based medical device producer backed by pharmaceutical firms GlaxoSmithKline and Johnson & Johnson as well as care provider DaVita HealthCare Partners, secured $126m in an upsized initial public offering on Wednesday.
The company issued 7 million shares on the Nasdaq Global Select Market on Wednesday priced at $18 each, above its $15 to $17 range. The shares closed at $26.07 yesterday, giving it a market capitalisation of $520m.
Founded in 2001, CVRx is marketing a medical device called…
